• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制具有t(X;1)(p11.2;q21.2)的两个乳头状肾癌细胞系中的X染色体断点,并首次报告一例女性病例。

Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.

作者信息

Shipley J M, Birdsall S, Clark J, Crew J, Gill S, Linehan M, Gnarra J, Fisher S, Craig I W, Cooper C S

机构信息

Molecular Cytogenetics Laboratory, Institute of Cancer Research, Belmont, Sutton, Surrey, UK.

出版信息

Cytogenet Cell Genet. 1995;71(3):280-4. doi: 10.1159/000134127.

DOI:10.1159/000134127
PMID:7587394
Abstract

A t(X;1)(p11.2;q21.2) has been reported in cases of papillary renal cell tumors arising in males. In this study two cell lines derived from this tumor type have been used to indicate the breakpoint region on the X chromosome. Both cell lines have the translocation in addition to other rearrangements and one is derived from the first female case to be reported with the t(X;1)(p11.2;q21.2). Fluorescence in situ hybridization (FISH) has been used to position YACs belonging to contigs in the Xp11.2 region relative to the breakpoint. When considered together with detailed mapping information from the Xp11.2 region the position of the breakpoint in both cell lines was suggested as follows: Xpter-->Xp11.23-OATL1-GATA1-WAS-TFE3-SY P-t(X;1)-DXS255-CLCN5-DXS146-OATL2- Xp11.22-->Xcen. The breakpoint was determined to lie in an uncloned region between SYP and a YAC called FTDM/1 which extends 1 Mb distal to DXS255. These results are contrary to the conclusion from previous FISH studies that the breakpoint was near the OATL2 locus, but are consistent with, and considerably refine, the position that had been established by molecular analysis.

摘要

在男性发生的乳头状肾细胞肿瘤病例中曾报道过t(X;1)(p11.2;q21.2)。在本研究中,源自这种肿瘤类型的两个细胞系被用于确定X染色体上的断点区域。两个细胞系除了有其他重排外都有这种易位,其中一个源自首例报道的患有t(X;1)(p11.2;q21.2)的女性病例。荧光原位杂交(FISH)已被用于将属于重叠群的YAC定位在相对于断点的Xp11.2区域。当与来自Xp11.2区域的详细图谱信息一起考虑时,两个细胞系中断点的位置如下所示:Xpter→Xp11.23 - OATL1 - GATA1 - WAS - TFE3 - SY P - t(X;1) - DXS255 - CLCN5 - DXS146 - OATL2 - Xp11.22→Xcen。断点被确定位于SYP和一个名为FTDM/1的YAC之间的一个未克隆区域,该YAC在DXS255远端延伸1 Mb。这些结果与先前FISH研究得出的断点位于OATL2基因座附近的结论相反,但与分子分析所确定的位置一致,并对其进行了相当大的细化。

相似文献

1
Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.绘制具有t(X;1)(p11.2;q21.2)的两个乳头状肾癌细胞系中的X染色体断点,并首次报告一例女性病例。
Cytogenet Cell Genet. 1995;71(3):280-4. doi: 10.1159/000134127.
2
Molecular cloning of the papillary renal cell carcinoma-associated translocation (X;1)(p11;q21) breakpoint.
Cytogenet Cell Genet. 1996;75(1):2-6. doi: 10.1159/000134444.
3
Identification of a yeast artificial chromosome that spans the human papillary renal cell carcinoma-associated t(X;1) breakpoint in Xp11.2.鉴定一个跨越Xp11.2上人类乳头状肾细胞癌相关t(X;1)断点的酵母人工染色体。
Cancer Genet Cytogenet. 1993 Dec;71(2):164-9. doi: 10.1016/0165-4608(93)90024-g.
4
Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization.
Hum Mol Genet. 1992 Nov;1(8):633-7. doi: 10.1093/hmg/1.8.633.
5
Construction of two YAC contigs in human Xp11.23-p11.22, one encompassing the loci OATL1, GATA, TFE3, and SYP, the other linking DXS255 to DXS146.
Genomics. 1995 Sep 20;29(2):496-502. doi: 10.1006/geno.1995.9976.
6
Fine mapping of the 1q21 breakpoint of the papillary renal cell carcinoma-associated (X;1) translocation.乳头状肾细胞癌相关(X;1)易位中1q21断点的精细定位。
Hum Genet. 1996 Jul;98(1):16-21. doi: 10.1007/s004390050153.
7
The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome.在人类滑膜肉瘤中发现的t(X;18)(p11.2;q11.2)易位涉及X染色体上两个不同的基因座。
Oncogene. 1994 May;9(5):1447-53.
8
Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma.3p14区域YAC克隆的多色荧光原位杂交定位以及一个跨越FRA3B和与遗传性肾细胞癌相关的t(3;8)的YAC的鉴定。
Genomics. 1994 Jul 15;22(2):319-26. doi: 10.1006/geno.1994.1390.
9
Localization of X chromosome short arm markers relative to synovial sarcoma- and renal adenocarcinoma-associated translocation breakpoints.
Hum Genet. 1993 Oct 1;92(3):305-8. doi: 10.1007/BF00244478.
10
Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females.两例女性伴有t(X;1)(p11;q21)的乳头状肾细胞癌新病例。
Cancer Genet Cytogenet. 1999 Apr;110(1):54-6. doi: 10.1016/s0165-4608(98)00181-2.

引用本文的文献

1
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis.缺氧诱导因子1α通过调控向脂肪酸合成的代谢转变,在TFE3重排肾细胞癌的发展中起关键作用。
Genes Cells. 2025 Jan;30(1):e13195. doi: 10.1111/gtc.13195.
2
The GATOR2 complex maintains lysosomal-autophagic function by inhibiting the protein degradation of MiT/TFEs.GATOR2 复合物通过抑制 MiT/TFE 的蛋白降解来维持溶酶体自噬功能。
Mol Cell. 2024 Feb 15;84(4):727-743.e8. doi: 10.1016/j.molcel.2024.01.012. Epub 2024 Feb 6.
3
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
高通量和靶向药物筛选鉴定针对 MiT 易位肾细胞癌的药理学候选物。
J Exp Clin Cancer Res. 2023 Apr 25;42(1):99. doi: 10.1186/s13046-023-02667-4.
4
A primary rectal neoplasm with novel DDX5-TFEB fusion.具有新型 DDX5-TFEB 融合的直肠原发性肿瘤。
Virchows Arch. 2022 Sep;481(3):511-516. doi: 10.1007/s00428-022-03316-5. Epub 2022 Apr 9.
5
Xp11.2 Translocation Renal Cell Carcinoma With Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.伴有重排的Xp11.2易位性肾细胞癌:不同融合伴侣的独特形态学特征及预后
Front Oncol. 2021 Nov 30;11:784993. doi: 10.3389/fonc.2021.784993. eCollection 2021.
6
MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer.转录因子的MiT/TFE家族、溶酶体与癌症
Annu Rev Cancer Biol. 2019 Mar;3:203-222. doi: 10.1146/annurev-cancerbio-030518-055835. Epub 2018 Nov 28.
7
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.TFE3 Xp11.2 易位肾细胞癌小鼠模型揭示了新的治疗靶点,并鉴定 GPNMB 为人类疾病的诊断标志物。
Mol Cancer Res. 2019 Aug;17(8):1613-1626. doi: 10.1158/1541-7786.MCR-18-1235. Epub 2019 May 1.
8
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.PRCC-TFE3双融合荧光原位杂交检测:一种在石蜡包埋组织中识别PRCC-TFE3肾细胞癌的新方法。
PLoS One. 2017 Sep 26;12(9):e0185337. doi: 10.1371/journal.pone.0185337. eCollection 2017.
9
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.TFE3和TFEB融合性肾癌的分子遗传学与细胞特征
Nat Rev Urol. 2014 Aug;11(8):465-75. doi: 10.1038/nrurol.2014.162. Epub 2014 Jul 22.
10
The metabolic basis of kidney cancer.肾脏癌的代谢基础。
Semin Cancer Biol. 2013 Feb;23(1):46-55. doi: 10.1016/j.semcancer.2012.06.002. Epub 2012 Jun 13.